{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:15:12Z","timestamp":1789758912154,"version":"4.0.1"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88882.182182\/2018-01"],"award-info":[{"award-number":["88882.182182\/2018-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.imlet.2019.08.009","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T10:47:17Z","timestamp":1567248437000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis"],"prefix":"10.1016","volume":"214","author":[{"given":"Jean L.G.","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela F.","family":"Passos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane M.","family":"Bernardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela B.R.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2019.08.009_bib0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2019.08.009_bib0010","first-page":"673","article-title":"Polygenic susceptibility in rheumatoid arthritis","volume":"15","author":"Wordsworth","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2019.08.009_bib0015","first-page":"1","article-title":"Prevalence of rheumatoid arthritis in low- and middle-income countries: a systematic review and analysis","volume":"5","author":"Rudan","year":"2015","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.imlet.2019.08.009_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.semarthrit.2015.06.010","article-title":"Development of a multimorbidity index: impact on quality of life using a rheumatoid arthritis cohort","volume":"45","author":"Radner","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.imlet.2019.08.009_bib0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/art.24428","article-title":"Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity","volume":"61","author":"Frederick","year":"2009","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.imlet.2019.08.009_bib0030","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2019.08.009_bib0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/ar4593","article-title":"The disease formerly known as rheumatoid arthritis","volume":"16","author":"Firestein","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2019.08.009_bib0040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.autrev.2016.03.003","article-title":"Autoantibodies in inflammatory arthritis","volume":"15","author":"Conigliaro","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2019.08.009_bib0045","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ncprheum0647","article-title":"Mechanisms of disease: angiogenesis in inflammatory diseases","volume":"3","author":"Szekanecz","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0055","doi-asserted-by":"crossref","DOI":"10.1136\/ard.62.suppl_2.ii60","article-title":"Angiogenesis as a target in rheumatoid arthritis","volume":"62","author":"Koch","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2019.08.009_bib0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","article-title":"Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade","volume":"1783","author":"Yegutkin","year":"2008","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.imlet.2019.08.009_bib0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.autrev.2010.07.019","article-title":"The role of adenosine receptors in rheumatoid arthritis","volume":"10","author":"Varani","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2019.08.009_bib0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pharmthera.2005.04.013","article-title":"Adenosine 5\u2032 -triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation","volume":"112","author":"Bours","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.imlet.2019.08.009_bib0075","series-title":"Adv. Pharmacol.","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385526-8.00001-1","article-title":"The structure of the adenosine receptors: implications for drug discovery","author":"Lane","year":"2011"},{"key":"10.1016\/j.imlet.2019.08.009_bib0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.imlet.2019.08.009_bib0085","first-page":"716","article-title":"Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate","volume":"18","author":"Ryan","year":"1991","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/1529-0131(199802)41:2<246::AID-ART8>3.0.CO;2-I","article-title":"ATP and UTP activate calcium\u2010mobilizing P2U\u2010like receptors and act synergistically with interleukin\u20101 to stimulate prostaglandin E2 release from human rheumatoid synovial cells","volume":"41","author":"Loredo","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2019.08.009_bib0095","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2019.08.009_bib0100","doi-asserted-by":"crossref","first-page":"e1629","DOI":"10.1038\/cddis.2014.576","article-title":"The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine","volume":"6","author":"Baron","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.imlet.2019.08.009_bib0105","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/nprot.2017.052","article-title":"Use of luciferase probes to measure ATP in living cells and animals","volume":"12","author":"Morciano","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.imlet.2019.08.009_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: all we need to know about danger","volume":"81","author":"Bianchi","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.1008647","article-title":"The endogenous Toll\u2013like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer","volume":"86","author":"Ehrchen","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0120","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.4049\/jimmunol.1202045","article-title":"Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis","volume":"190","author":"Killeen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nri.2016.124","article-title":"The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting","volume":"17","author":"Malmstr\u00f6m","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0130","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1002\/art.34649","article-title":"JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production","volume":"64","author":"LaBranche","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2019.08.009_bib0135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cbf.2910","article-title":"Activities of enzymes that hydrolyze adenine nucleotides in lymphocytes from patients with rheumatoid arthritis","volume":"31","author":"dos S. Jaques","year":"2013","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.imlet.2019.08.009_bib0140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/cbf.3188","article-title":"Free and nanoencapsulated vitamin D3: effects on E-NTPDase and E-ADA activities in an animal model with induced arthritis","volume":"34","author":"da Silveira","year":"2016","journal-title":"Cell Biochem. Funct."},{"issue":"4","key":"10.1016\/j.imlet.2019.08.009_bib0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11302-018-9619-2","article-title":"Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection","volume":"14","author":"Passos","year":"2018","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11302-006-9050-y","article-title":"CD39 and control of cellular immune responses","volume":"3","author":"Dwyer","year":"2007","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0155","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.4049\/jimmunol.1000108","article-title":"Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology","volume":"185","author":"Ernst","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/cei.12354","article-title":"Human CD4+CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells","volume":"177","author":"Schuler","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0165","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.0803474","article-title":"High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population","volume":"185","author":"Moncrieffe","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2014.12.007","article-title":"The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation","volume":"58","author":"Rissiek","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2019.08.009_bib0175","doi-asserted-by":"crossref","first-page":"16788","DOI":"10.1073\/pnas.0902869106","article-title":"CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease","volume":"106","author":"Friedman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2019.08.009_bib0180","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.190.Supp.175.4","article-title":"Autoimmune susceptibility gene critically influences CD39 T cell expression and function in modulating human inflammation (P3313)","author":"Moncrieffe","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0185","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/1756-185X.13333","article-title":"CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis","volume":"21","author":"Gupta","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.imlet.2019.08.009_bib0190","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.38959","article-title":"Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis","volume":"67","author":"Botta Gordon\u2010Smith","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0195","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4161\/onci.20387","article-title":"CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma","volume":"1","author":"Mandapathil","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.imlet.2019.08.009_bib0200","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/408242","article-title":"Modulating P2X7 receptor signaling during rheumatoid arthritis: new therapeutic approaches for bisphosphonates","volume":"2012","author":"Baroja-Mazo","year":"2012","journal-title":"J. Osteoporos."},{"key":"10.1016\/j.imlet.2019.08.009_bib0205","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00018-007-6497-0","article-title":"Purine and pyrimidine receptors","volume":"64","author":"Burnstock","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.imlet.2019.08.009_bib0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1242\/jcs.112.3.297","article-title":"Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release","volume":"112","author":"Solini","year":"2017","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.imlet.2019.08.009_bib0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2019.08.009_bib0220","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1744-313X.2011.01019.x","article-title":"P2X7 receptor gene polymorphism analysis in rheumatoid arthritis","volume":"38","author":"Al-Shukaili","year":"2011","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.imlet.2019.08.009_bib0225","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.humimm.2010.05.008","article-title":"Expression and function of the P2X7 purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"71","author":"Portales-Cervantes","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0230","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10753-007-9052-0","article-title":"A comparative study of Interleukin-1\u03b2 production and P2X7 expression after Atp stimulation by peripheral blood mononuclear cells isolated from rheumatoid arthritis patients and normal healthy controls","volume":"31","author":"Al-Shukaili","year":"2008","journal-title":"Inflammation"},{"key":"10.1016\/j.imlet.2019.08.009_bib0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2018.03.016","article-title":"The purinergic P2X7 ion channel receptor\u2014a \u2018repair\u2019 receptor in bone","volume":"52","author":"J\u00f8rgensen","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0240","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.1000436","article-title":"P2X7 receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases","volume":"185","author":"Lopez-Castejon","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0245","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1096\/fj.12-205765","article-title":"P2X7 receptor-stimulation causes fever via PGE2 and IL-1\u03b2 release","volume":"26","author":"Barber\u00e0-Cremades","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.imlet.2019.08.009_bib0250","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.12659\/MSM.895116","article-title":"Serum levels of IL-6 and TNF-\u03b1 may correlate with activity and severity of rheumatoid arthritis","volume":"21","author":"Wei","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.imlet.2019.08.009_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070210","article-title":"P2X4 assembles with P2X7 and pannexin-1 in gingival epithelial cells and modulates ATP-induced reactive oxygen species production and inflammasome activation","volume":"8","author":"Hung","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2019.08.009_bib0260","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4049\/jimmunol.1202388","article-title":"Neutrophil extracellular trap\u2013associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages","volume":"190","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0265","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2019.08.009_bib0270","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2000549","article-title":"Purinergic signaling: a fundamental mechanism in neutrophil activation","volume":"3","author":"Chen","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0275","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1517\/13543784.2011.578068","article-title":"A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases","volume":"20","author":"Arulkumaran","year":"2011","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.imlet.2019.08.009_bib0280","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/glia.22628","article-title":"P2X7\u2010dependent, but differentially regulated release of IL\u20106, CCL2, and TNF\u2010\u03b1 in cultured mouse microglia","volume":"62","author":"Chu-Hsin","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.imlet.2019.08.009_bib0285","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1074\/jbc.M207868200","article-title":"Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation","volume":"278","author":"Loomis","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2019.08.009_bib0290","first-page":"35804","article-title":"Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice, Sci","volume":"6","author":"Fan","year":"2016","journal-title":"Rep."},{"key":"10.1016\/j.imlet.2019.08.009_bib0295","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00296-011-1984-x","article-title":"Disturbed Th17\/Treg balance in patients with rheumatoid arthritis","volume":"32","author":"Niu","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.imlet.2019.08.009_bib0300","doi-asserted-by":"crossref","first-page":"ra12","DOI":"10.1126\/scisignal.2001270","article-title":"ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors","volume":"4","author":"Schenk","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0305","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ceca.2011.08.002","article-title":"Gain-of-function of P2X7 receptor gene variants in multiple sclerosis","volume":"50","author":"Oyanguren-Desez","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/j.imlet.2019.08.009_bib0310","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","article-title":"The P2X7 receptor: a main player in inflammation","volume":"151","author":"Adinolfi","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0315","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nm.2710","article-title":"Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity","volume":"18","author":"Sorge","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2019.08.009_bib0320","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2019.08.009_bib0325","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.autrev.2019.06.009","article-title":"P2X7 receptor: a potential therapeutic target for autoimmune diseases","volume":"18","author":"Cao","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2019.08.009_bib0330","doi-asserted-by":"crossref","first-page":"366ra162","DOI":"10.1126\/scitranslmed.aaf8463","article-title":"Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation","volume":"8","author":"Danquah","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2019.08.009_bib0335","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.4049\/jimmunol.168.12.6436","article-title":"Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response","volume":"168","author":"Labasi","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0340","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1002\/art.30556","article-title":"Pharmacologic P2X purinergic receptor antagonism in the treatment of collagen\u2010induced arthritis","volume":"63","author":"Vittoria","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2019.08.009_bib0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11302-008-9110-6","article-title":"Selective P2X7 receptor antagonists for chronic inflammation and pain","volume":"5","author":"Carroll","year":"2008","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0350","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0355","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2019.08.009_bib0360","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpain.2016.10.008","article-title":"Intra-articular blockade of P2X7 receptor reduces the articular hyperalgesia and inflammation in the knee joint synovitis especially in female rats","volume":"18","author":"Teixeira","year":"2017","journal-title":"J. Pain"},{"key":"10.1016\/j.imlet.2019.08.009_bib0365","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/ATVBAHA.111.226837","article-title":"Regulation of lymphocyte function by adenosine","volume":"32","author":"Linden","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0370","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/pr.113.008003","article-title":"The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease","volume":"66","author":"Bartlett","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.imlet.2019.08.009_bib0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.reuma.2010.10.007","article-title":"Biomarcadores en la artritis reumatoide","volume":"6","author":"Sanmart\u00ed","year":"2011","journal-title":"Reumatol. Cl\u00edn."},{"key":"10.1016\/j.imlet.2019.08.009_bib0380","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2019.08.009_bib0385","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ni.3054","article-title":"Pathophysiology of T follicular helper cells in humans and mice","volume":"16","author":"Ueno","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0390","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.immuni.2014.10.010","article-title":"ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer\u2019s patches to promote host-microbiota mutualism","volume":"41","author":"Proietti","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2019.08.009_bib0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006595","article-title":"P2X7 receptor drives Th1 cell differentiation and controls the follicular helper T cell population to protect against Plasmodium chabaudi malaria","volume":"13","author":"de Salles","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imlet.2019.08.009_bib0400","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fimmu.2019.00411","article-title":"P2RX7 deletion in T cells promotes autoimmune arthritis by unleashing the Tfh cell response","volume":"10","author":"Felix","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0405","first-page":"13","article-title":"Adenosine and adenosine receptors in rheumatoid arthritis","volume":"8","author":"Padovan","year":"2013","journal-title":"Int. J. Clin."},{"key":"10.1016\/j.imlet.2019.08.009_bib0410","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.imlet.2019.08.009_bib0415","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","article-title":"Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases","volume":"13","author":"Cronstein","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0420","series-title":"Adenosine Recept. Heal. Dis.","first-page":"215","article-title":"Adenosine receptors and inflammation","author":"Blackburn","year":"2009"},{"key":"10.1016\/j.imlet.2019.08.009_bib0425","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/ijms18040697","article-title":"Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis","volume":"18","author":"Ravani","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2019.08.009_bib0430","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.imlet.2019.08.009_bib0435","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/mol.108.048066","article-title":"Activation of the A3 adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils","volume":"74","author":"van der Hoeven","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0440","series-title":"Adv. Pharmacol.","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-12-385526-8.00002-3","article-title":"Adenosine receptors in health and disease","author":"Gessi","year":"2011"},{"key":"10.1016\/j.imlet.2019.08.009_bib0445","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.imbio.2011.03.008","article-title":"Suppression of inflammation response by a novel A3 adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-\u03baB signaling","volume":"216","author":"Lee","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.imlet.2019.08.009_bib0450","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bcp.2008.05.032","article-title":"The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB\/Akt and NF-\u03baB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats","volume":"76","author":"Ochaion","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0455","doi-asserted-by":"crossref","first-page":"C530","DOI":"10.1152\/ajpcell.00385.2010","article-title":"Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells","volume":"301","author":"Romio","year":"2011","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0460","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2019.08.009_bib0465","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V90.4.1600","article-title":"Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2019.08.009_bib0470","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.1424792112","article-title":"Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis","volume":"112","author":"Peres","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2019.08.009_bib0475","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1476-5381.2010.00668.x","article-title":"A2b adenosine receptors can change their spots","volume":"159","author":"Cohen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0480","first-page":"1","article-title":"Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection","author":"Passos","year":"2018","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0485","first-page":"41","article-title":"Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial","volume":"35","author":"Silverman","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0490","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11302-012-9292-9","article-title":"Adenosine A 1 receptor regulates osteoclast formation by altering TRAF6\/TAK1 signaling","volume":"8","author":"He","year":"2012","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0495","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/labinvest.2011.9","article-title":"Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis","volume":"91","author":"Teramachi","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.imlet.2019.08.009_bib0500","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1096\/fj.09-147447","article-title":"Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function","volume":"24","author":"Kara","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.imlet.2019.08.009_bib0505","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1096\/fj.10-169854","article-title":"P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration","volume":"25","author":"Pellegatti","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.imlet.2019.08.009_bib0510","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","article-title":"Methotrexate\u2014how does it really work?","volume":"6","author":"Chan","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2019.08.009_bib0515","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.imlet.2019.08.009_bib0520","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/art.24794","article-title":"Normalization of A2A and A3 adenosine receptor up\u2010regulation in rheumatoid arthritis patients by treatment with anti\u2013tumor necrosis factor \u03b1 but not methotrexate","volume":"60","author":"Katia","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2019.08.009_bib0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054195","article-title":"A2A adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats","volume":"8","author":"Vincenzi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2019.08.009_bib0530","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3899\/jrheum.110111","article-title":"CGS 21680, an agonist of the Adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis","volume":"38","author":"Mazzon","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0535","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1476-5381.2010.00667.x","article-title":"Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes","volume":"160","author":"Varani","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0540","first-page":"400","article-title":"IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis","volume":"24","author":"Rath-Wolfson","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0545","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s10067-016-3202-4","article-title":"The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis","volume":"35","author":"Fishman","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0550","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2019.08.009_bib0555","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nm.4267","article-title":"Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states","volume":"23","author":"Furman","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2019.08.009_bib0560","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.4049\/jimmunol.164.9.4893","article-title":"Kinetics and mechanism of ATP-dependent IL-1\u03b2 release from microglial cells","volume":"164","author":"Sanz","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0565","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/ncomms3909","article-title":"Adenosine is required for sustained inflammasome activation via the A 2A receptor and the HIF-1\u03b1 pathway","volume":"4","author":"Ouyang","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2019.08.009_bib0570","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0898-6568(03)00058-5","article-title":"Signalling from adenosine receptors to mitogen-activated protein kinases","volume":"15","author":"Schulte","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0575","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1189\/jlb.0107060","article-title":"Adenosine A2a receptor\u2010mediated, normoxic induction of HIF\u20101 through PKC and PI\u20103K\u2010dependent pathways in macrophages","volume":"82","author":"De Ponti","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0580","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1124\/jpet.103.052944","article-title":"cDNA microarray analysis reveals a nuclear factor-\u03baB-independent regulation of macrophage function by adenosine","volume":"306","author":"N\u00e9emeth","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.imlet.2019.08.009_bib0585","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/ncomms2684","article-title":"Prostaglandin E2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase","volume":"4","author":"Yao","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2019.08.009_bib0590","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cellsig.2010.11.018","article-title":"Cyclic AMP-mediated immune regulation\u2014overview of mechanisms of action in T cells","volume":"23","author":"Mosenden","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0595","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09723757.2006.11885963","article-title":"Serum ADA and C-reactive protein in rheumatoid arthritis","volume":"6","author":"Rani","year":"2006","journal-title":"Int. J. Hum. Genet."},{"key":"10.1016\/j.imlet.2019.08.009_bib0600","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1874312901408010024","article-title":"Serum adenosine deaminase level is high but not related with disease activity parameters in patients with rheumatoid arthritis","volume":"8","author":"Demir","year":"2014","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.imlet.2019.08.009_bib0605","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/art.10956","article-title":"Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts","volume":"48","author":"Yuji","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2019.08.009_bib0610","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s100670170005","article-title":"Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus","volume":"20","author":"Hitoglou","year":"2001","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0615","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/138945012800564095","article-title":"Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders","author":"Antonioli","year":"2012","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.imlet.2019.08.009_bib0620","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/2279-042X.108374","article-title":"Serum adenosine deaminase in patients with rheumatoid arthritis treated with methotrexate","volume":"1","author":"Salesi","year":"2012","journal-title":"J. Res. Pharm. Pract."},{"key":"10.1016\/j.imlet.2019.08.009_bib0625","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00296-011-1912-0","article-title":"Serum adenosine deaminase may predict disease activity in rheumatoid arthritis","volume":"32","author":"Zamani","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.imlet.2019.08.009_bib0630","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1573397114666180406101239","article-title":"Adenosine deaminase activity and HLA-DRB as diagnostic markers for rheumatoid arthritis","volume":"15","author":"Valadbeigi","year":"2019","journal-title":"Curr. Rheumatol. Rev."},{"key":"10.1016\/j.imlet.2019.08.009_bib0635","first-page":"BC08","article-title":"Serum adenosine deaminase as inflammatory marker in rheumatoid arthritis","volume":"9","author":"Vinapamula","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.imlet.2019.08.009_bib0640","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00296-008-0750-1","article-title":"Assessment of adenosine deaminase levels in rheumatoid arthritis patients receiving anti-TNF-\u03b1 therapy","volume":"29","author":"Erer","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.imlet.2019.08.009_bib0645","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejr.2018.05.005","article-title":"Performance of serum adenosine deaminase in measuring disease activity in rheumatoid arthritis patients","volume":"41","author":"Hameed","year":"2018","journal-title":"Egypt. Rheumatol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0650","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.4049\/jimmunol.155.10.4630","article-title":"Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule","volume":"155","author":"Martin","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051287","article-title":"Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals","volume":"7","author":"Casanova","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2019.08.009_bib0660","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fimmu.2018.00399","article-title":"Purinergic regulation of neutrophil function","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0665","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11302-012-9322-7","article-title":"Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas disease","volume":"8","author":"do C.G. Souza","year":"2012","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.imlet.2019.08.009_bib0670","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1007\/s13277-016-5005-2","article-title":"DPPIV\/CD26: a tumor suppressor or a marker of malignancy?","volume":"37","author":"Beckenkamp","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00106","article-title":"Molecular evidence of adenosine deaminase linking adenosine A2A receptor and CD26 proteins","volume":"9","author":"Moreno","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0680","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/606031","article-title":"Recent advances in dipeptidyl-peptidase-4 inhibition therapy: lessons from the bench and clinical trials","volume":"2015","author":"Zhong","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.imlet.2019.08.009_bib0685","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1073\/pnas.0501050102","article-title":"CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse","volume":"102","author":"Pacheco","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2019.08.009_bib0690","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1743-422X-7-343","article-title":"CD26\/dipeptidyl peptidase IV (CD26\/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected female sex workers","volume":"7","author":"Songok","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.imlet.2019.08.009_bib0695","article-title":"CD26 expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis","volume":"10","author":"Cordero","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2019.08.009_bib0700","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1103801","article-title":"Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26)","author":"Bengsch","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0705","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3083.2007.01966.x","article-title":"In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4+ T lymphocytes","volume":"66","author":"Ellingsen","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0710","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2249.1994.tb06134.x","article-title":"Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients","volume":"98","author":"Muscat","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2019.08.009_bib0715","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1186\/ar3527","article-title":"A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release","volume":"13","author":"Varani","year":"2011","journal-title":"Arthritis Res. Ther."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819303487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819303487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:15:00Z","timestamp":1778670900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247819303487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":143,"alternative-id":["S0165247819303487"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2019.08.009","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2019.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Immunological Societies. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}